Drug Topics - November 12, 2007 - (Page 19) 19 We want your feedback FDA explains new user fee program for DTC TV ads In the Oct. 25 Federal Register, the FDA is asking companies to notify the agency within 30 calendar days if they intend to participate in the direct-to-consumer (DTC) user fee program during fiscal year 2008. If they do plan to participate, the firms are also asked to identify the number of TV ads for prescription drugs and biological products they plan to submit for advisory review during fiscal year 2008. Written responses should be submitted by Nov. 26. Responses can be e-mailed to dtcp@fda.hhs.gov. The new user fee program was established by the FDA Amendments Act of 2007. NACDS member testifies on organized retail crime at hearing Brad Brekke, VP of assets protection for NACDS member Target Corp., testified on behalf of the Coalition Against Organized Retail Crime before the House Subcommittee on Crime, Terrorism, and Homeland Security. The hearing was titled “Organized Retail Theft Prevention: Fostering a Comprehensive Public Private Response.” Items often targeted by organized retail gangs include infant formula, razor blades, batteries, analgesics, teeth whitening strips, franchise cosmetics, and gift cards. More expensive products, such as DVDs, CDs, video games, iPods, designer clothes, and electronics are also highly prized among organized retail crime rings. NACDS president/CEO Steven Anderson said, “Organized retail crime drains businesses, penalizes consumers, and sustains illegal activities that threaten communities. We applaud chairman Bobby Scott (D, Va.) and his colleagues for working to address this serious problem.” The Retail Industry Leaders Association (RILA) also commended chairman Scott for holding the hearing. RILA’s executive VP Lori Denham said, “Organized retail crime is of great importance to consumers whose safety is jeopardized by the tampering, repackaging, relabeling, and reselling of many popular retail products such as OTC medications and infant formula.” How do you like Drug Topics’ digital edition? Please fill out this short survey and give us your opinion. If you would like to submit a guest commentary, please e-mail your article to drugtopics@advanstar.com. DRUG TOPICS EDITORIAL ADVISORY BOARD MEMBERS Philip P. Burgess, R.Ph. M.B.A. National Director, Pharmacy Affairs Walgreen Co. Deerfield, Ill. Calvin H. Knowlton, R.Ph., M.Div., Ph.D., CEO execJet USA Inc. Moorestown, N.J. Perry Cohen, Pharm.D., FAMCP The Pharmacy Group LLC Glastonbury, Conn. Frederick S. Mayer, R.Ph., M.P.H. President Pharmacists Planning Service Inc. San Rafael, Calif. David J. Fong, Pharm.D. Senior Vice President Pharmacy & Family Care Safeway Inc. Pleasanton, Calif. Gene Memoli Jr., R.Ph., FASCP Director of Customer Development Omnicare Cheshire, Conn. Patient files lawsuit against Walgreens for medication error A lawsuit against Walgreens has been filed in federal court by a woman who claims that a medication error caused her to have a miscarriage. Instead of being given a prescription for Materna, a prenatal vitamin, she received Matulane (procarbazine HCl, Sigma-Tau Pharmaceuticals), a chemotherapy drug used to treat Hodgkin’s disease. The patient said her prescription was filled at a Walgreens pharmacy near her suburban St. Louis, Mo., home. Walgreens said it has reached a resolution with the family and declined further comment. DT Mary E. Inguanti, R.Ph., M.P.H. Vice President of Operations Saint Francis Hospital and Medical Center Hartford, Conn. Jack Rosenberg, Pharm.D., Ph.D. Professor and Director of International Drug Information Center Arnold & Marie Schwartz College of Pharmacy & Health Sciences, Long Island University Brooklyn, N.Y. James A. Jorgenson, R.Ph., M.S., FASHP Director of Pharmacy Services University of Utah Hospitals & Clinics Associate Dean for Clinical Education University of Utah College of Pharmacy Salt Lake City, Utah Stephen W. Schondelmeyer, Pharm.D., Ph.D. Director, PRIME Institute College of Pharmacy University of Minnesota Minneapolis, Minn. http://a257.g.akamaitech.net/7/257/2422/01jan20071800/edocket.access.gpo.gov/2007/07-5282.htm http://www.drugtopics.com/drugtopics/form/formDetail.jsp?formId=469757> http://www.nacds.org/user-assets/pdfs/newsrelease/2007/Brekke.pdf
Table of Contents Feed for the Digital Edition of Drug Topics - November 12, 2007 Drug Topics - November 12, 2007 Contents Drugs Often Associated with Errors Wanted: More Convers to Drug Decision Tools MSRA Takeoff Raising Alarm Bells U.S. Still Volnerable to Drug Counterfeiting Strange Rx Stories: Are You Stupid? Are Students a Squandered Opportunity The Week at a Glance Drug Topics - November 12, 2007 Drug Topics - November 12, 2007 - Contents (Page Cover1) Drug Topics - November 12, 2007 - Contents (Page 2) Drug Topics - November 12, 2007 - Contents (Page 3) Drug Topics - November 12, 2007 - Drugs Often Associated with Errors (Page 4) Drug Topics - November 12, 2007 - Drugs Often Associated with Errors (Page 5) Drug Topics - November 12, 2007 - Wanted: More Convers to Drug Decision Tools (Page 6) Drug Topics - November 12, 2007 - MSRA Takeoff Raising Alarm Bells (Page 7) Drug Topics - November 12, 2007 - U.S. Still Volnerable to Drug Counterfeiting (Page 8) Drug Topics - November 12, 2007 - U.S. Still Volnerable to Drug Counterfeiting (Page 9) Drug Topics - November 12, 2007 - U.S. Still Volnerable to Drug Counterfeiting (Page 10) Drug Topics - November 12, 2007 - Strange Rx Stories: Are You Stupid? (Page 11) Drug Topics - November 12, 2007 - Are Students a Squandered Opportunity (Page 12) Drug Topics - November 12, 2007 - Are Students a Squandered Opportunity (Page 13) Drug Topics - November 12, 2007 - The Week at a Glance (Page 14) Drug Topics - November 12, 2007 - The Week at a Glance (Page 15) Drug Topics - November 12, 2007 - The Week at a Glance (Page 16) Drug Topics - November 12, 2007 - The Week at a Glance (Page 17) Drug Topics - November 12, 2007 - The Week at a Glance (Page 18) Drug Topics - November 12, 2007 - The Week at a Glance (Page 19)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.